Kohei Togami

569 total citations
43 papers, 473 citations indexed

About

Kohei Togami is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Kohei Togami has authored 43 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Kohei Togami's work include Inhalation and Respiratory Drug Delivery (19 papers), Pneumonia and Respiratory Infections (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Kohei Togami is often cited by papers focused on Inhalation and Respiratory Drug Delivery (19 papers), Pneumonia and Respiratory Infections (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Kohei Togami collaborates with scholars based in Japan, United States and Iraq. Kohei Togami's co-authors include Sumio Chono, Kazuhiro Morimoto, Hitoshi Tada, Eri Yamamoto, Toshinobu Seki, Hirokazu Suzuki, Shirou Itagaki, Kei Miyakoshi, Shinya Yamazaki and Shingo Sato and has published in prestigious journals such as Frontiers in Immunology, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Kohei Togami

39 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kohei Togami Japan 14 261 93 88 66 56 43 473
Kaushlendra Kumar India 6 233 0.9× 90 1.0× 47 0.5× 129 2.0× 22 0.4× 8 344
Jahidur Rashid United States 14 188 0.7× 17 0.2× 75 0.9× 43 0.7× 35 0.6× 17 423
Zachary N. Warnken United States 13 158 0.6× 46 0.5× 136 1.5× 232 3.5× 13 0.2× 19 494
Dale Meisner Canada 11 241 0.9× 38 0.4× 121 1.4× 157 2.4× 27 0.5× 14 639
Stephanie Wallace Australia 9 54 0.2× 76 0.8× 119 1.4× 103 1.6× 113 2.0× 11 507
Marius Hittinger Germany 14 266 1.0× 30 0.3× 203 2.3× 215 3.3× 15 0.3× 26 664
Gina Eagle United States 13 105 0.4× 243 2.6× 110 1.3× 22 0.3× 79 1.4× 39 598
Peter Hodsman United States 11 91 0.3× 109 1.2× 120 1.4× 14 0.2× 42 0.8× 18 677
Ralph Woessner Switzerland 18 171 0.7× 87 0.9× 433 4.9× 20 0.3× 35 0.6× 62 958
T Velpandian India 15 50 0.2× 115 1.2× 73 0.8× 59 0.9× 45 0.8× 31 628

Countries citing papers authored by Kohei Togami

Since Specialization
Citations

This map shows the geographic impact of Kohei Togami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Togami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Togami more than expected).

Fields of papers citing papers by Kohei Togami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Togami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Togami. The network helps show where Kohei Togami may publish in the future.

Co-authorship network of co-authors of Kohei Togami

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Togami. A scholar is included among the top collaborators of Kohei Togami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Togami. Kohei Togami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Togami, Kohei, Whitney Wolf, Limei Shen, et al.. (2024). Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium. Frontiers in Immunology. 15. 1371156–1371156. 2 indexed citations
3.
Togami, Kohei, et al.. (2023). Development of a Compensated Förster Resonance Energy Transfer Imaging for Improved Assessment of the Intrapulmonary Distribution of Polymeric Nanoparticles. Journal of Pharmaceutical Sciences. 112(10). 2696–2702. 2 indexed citations
6.
Togami, Kohei, et al.. (2020). Multiscale Live Imaging Using Förster Resonance Energy Transfer (FRET) for Evaluating the Biological Behavior of Nanoparticles as Drug Carriers. Journal of Pharmaceutical Sciences. 109(12). 3608–3616. 6 indexed citations
7.
Togami, Kohei, et al.. (2019). Evaluation of various tissue-clearing techniques for the three-dimensional visualization of liposome distribution in mouse lungs at the alveolar scale. International Journal of Pharmaceutics. 562. 218–227. 12 indexed citations
8.
Togami, Kohei, et al.. (2018). FACILE AND SENSITIVE HPLC-UV METHOD FOR DETERMINATION OF NINTEDANIB IN RAT PLASMA. International Journal of Pharmacy and Pharmaceutical Sciences. 10(6). 133–133. 13 indexed citations
9.
Togami, Kohei, et al.. (2017). Inhibitory Effect of Young Barley Grass Extract Powder on Body Weight Increase and Visceral Fat Accumulation in Mice Fed a High-fat diet. 93. 13–18. 1 indexed citations
11.
Togami, Kohei, Eri Yamamoto, Shujun Wang, et al.. (2016). Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces. Drug Delivery and Translational Research. 6(5). 565–571. 11 indexed citations
12.
Togami, Kohei, Sumio Chono, & Hitoshi Tada. (2016). Alteration in Intrapulmonary Pharmacokinetics of Aerosolized Model Compounds Due to Disruption of the Alveolar Epithelial Barriers Following Bleomycin-Induced Pulmonary Fibrosis in Rats. Journal of Pharmaceutical Sciences. 105(3). 1327–1334. 6 indexed citations
13.
Togami, Kohei, Yoshiaki Hayashi, Sumio Chono, & Kazuhiro Morimoto. (2014). Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin. Biopharmaceutics & Drug Disposition. 35(6). 321–329. 9 indexed citations
14.
Yoshida, Kenji, Eri Tanaka, Kohei Togami, et al.. (2013). Dexmedetomidine decreases the oral mucosal blood flow. British Journal of Oral and Maxillofacial Surgery. 51(8). 928–931. 14 indexed citations
15.
Togami, Kohei, Sumio Chono, & Kazuhiro Morimoto. (2012). Aerosol-Based Efficient Delivery of Clarithromycin, a Macrolide Antimicrobial Agent, to Lung Epithelial Lining Fluid and Alveolar Macrophages for Treatment of Respiratory Infections. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25(2). 110–115. 19 indexed citations
16.
Togami, Kohei, Sumio Chono, & Kazuhiro Morimoto. (2012). Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells.. PubMed. 67(5). 389–93. 18 indexed citations
17.
Togami, Kohei, Sumio Chono, & Kazuhiro Morimoto. (2012). Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections. Pharmaceutical Development and Technology. 18(6). 1361–1365. 7 indexed citations
18.
Togami, Kohei, Sumio Chono, Toshinobu Seki, & Kazuhiro Morimoto. (2010). Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections. Drug Development and Industrial Pharmacy. 36(7). 861–866. 12 indexed citations
19.
Chono, Sumio, Hirokazu Suzuki, Kohei Togami, & Kazuhiro Morimoto. (2010). Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections. Drug Development and Industrial Pharmacy. 37(4). 367–372. 24 indexed citations
20.
Chono, Sumio, et al.. (2010). Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages. Drug Development and Industrial Pharmacy. 36(1). 102–107. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026